- Lobbying
- Lobbying by Medicine Access & Compliance Coalition
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Christopher Kapsch | n/a |
Liz Williams | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q4 Report
Q3 Report
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Health Resources & Services Administration (HRSA)
Office of Management & Budget (OMB)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Health Resources & Services Administration (HRSA)
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Health Resources & Services Administration (HRSA)
Type of Issue
Pharmacy
Registration
Issue(s) they said they’d lobby about: Preserving the 340B drug discount program while improving transparency and ensuring that program participants are operating within the original intent of the law..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate